Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-tumor necrosis factor (TNF) antibodies and compositions thereof

Anti-tumor necrosis factor (TNF) antibodies and compositions thereof

US Patent 12129292 · Granted Oct 29, 2024

Estimated economic value: $304,380,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
RNA polymerase variants for co-transcriptional capping2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumo2024